Literature DB >> 21113989

Prostate cancer: New insight into mechanisms of castration resistance.

Sarah Payton.   

Abstract

Entities:  

Year:  2010        PMID： 21113989     DOI： 10.1038/nrurol.2010.171

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  2 in total

1.  Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant.

Authors:  Shihua Sun; Cynthia C T Sprenger; Robert L Vessella; Kathleen Haugk; Kathryn Soriano; Elahe A Mostaghel; Stephanie T Page; Ilsa M Coleman; Holly M Nguyen; Huiying Sun; Peter S Nelson; Stephen R Plymate
Journal:  J Clin Invest       Date:  2010-07-19       Impact factor: 14.808

2.  Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor.

Authors:  Philip A Watson; Yinan F Chen; Minna D Balbas; John Wongvipat; Nicholas D Socci; Agnes Viale; Kwanghee Kim; Charles L Sawyers
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-07       Impact factor: 11.205
  2 in total
  3 in total

1.  Reducing the risk of false discovery enabling identification of biologically significant genome-wide methylation status using the HumanMethylation450 array.

Authors:  Haroon Naeem; Nicholas C Wong; Zac Chatterton; Matthew K H Hong; John S Pedersen; Niall M Corcoran; Christopher M Hovens; Geoff Macintyre
Journal:  BMC Genomics       Date:  2014-01-22       Impact factor: 3.969

2.  Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer.

Authors:  R Vatapalli; V Sagar; Y Rodriguez; J C Zhao; K Unno; S Pamarthy; B Lysy; J Anker; H Han; Y A Yoo; M Truica; Z R Chalmers; F Giles; J Yu; D Chakravarti; B Carneiro; S A Abdulkadir
Journal:  Nat Commun       Date:  2020-08-19       Impact factor: 14.919

Review 3.  Resistance to second generation antiandrogens in prostate cancer: pathways and mechanisms.

Authors:  Shiv Verma; Kumari Sunita Prajapati; Prem Prakash Kushwaha; Mohd Shuaib; Atul Kumar Singh; Shashank Kumar; Sanjay Gupta
Journal:  Cancer Drug Resist       Date:  2020-09-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.